Patents by Inventor Zhiming Ma

Zhiming Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12145886
    Abstract: The present disclosure provides a recycled powder concrete material for 3D printing construction and a preparation method therefor. The concrete material includes the following components by weight parts: cement: 1.0 part; recycled powder: 0.1-2.0 parts; recycled fine aggregate: 1.0-12.0 parts; nano titanium dioxide: 0.001-0.18 parts; high elastic modulus polyethylene fiber: 0.005-0.15 parts; redispersible latex powder: 0.002-0.1 parts; cellulose: 0.001-0.045 parts; activator: 0.01-0.30 parts; polycarboxylic acid water reducing agent: 0.005-0.2 parts; and water: 0.2-2.0 parts. According to the recycled powder concrete material for 3D printing construction, construction waste recycling powder technology is combined with 3D printing construction technology. The safety, applicability and durability of 3D printing recycled powder concrete material are further improved through the optimization of the recycled powder concrete formula.
    Type: Grant
    Filed: January 23, 2019
    Date of Patent: November 19, 2024
    Assignee: TONGJI UNIVERSITY
    Inventors: Jianzhuang Xiao, Zhiming Ma, Zhenhua Duan, Jiangtao Yu, Tao Ding
  • Publication number: 20240039777
    Abstract: This application discloses a modulation method, a demodulation method, and a communication apparatus, and relates to the field of communication technologies. The communication apparatus may obtain information bit sequences, divide the information bit sequences into G groups, then separately encode each group of information bit sequences to obtain r encoded bit sequences, map the r encoded bit sequences into a modulation symbol sequence, and output the modulation symbol sequence. The modulation method provided in embodiments of this application may implement a flexible compromise between complexity and robustness, and has a wider range of application.
    Type: Application
    Filed: October 13, 2023
    Publication date: February 1, 2024
    Inventors: Xianhao Meng, Xianbin Wang, Yongtang Shi, Guiying Yan, Zhiming Ma
  • Publication number: 20210261461
    Abstract: The present disclosure provides a recycled powder concrete material for 3D printing construction and a preparation method therefor. The concrete material includes the following components by weight parts: cement: 1.0 part; recycled powder: 0.1-2.0 parts; recycled fine aggregate: 1.0-12.0 parts; nano titanium dioxide: 0.001-0.18 parts; high elastic modulus polyethylene fiber: 0.005-0.15 parts; redispersible latex powder: 0.002-0.1 parts; cellulose: 0.001-0.045 parts; activator: 0.01-0.30 parts; polycarboxylic acid water reducing agent: 0.005-0.2 parts; and water: 0.2-2.0 parts. According to the recycled powder concrete material for 3D printing construction, construction waste recycling powder technology is combined with 3D printing construction technology. The safety, applicability and durability of 3D printing recycled powder concrete material are further improved through the optimization of the recycled powder concrete formula.
    Type: Application
    Filed: January 23, 2019
    Publication date: August 26, 2021
    Applicant: TongJi University
    Inventors: Jianzhuang XIAO, Zhiming MA, Zhenhua DUAN, Jiangtao YU, Tao DING
  • Publication number: 20160193268
    Abstract: An extract of Andrographis particulata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysaccharides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.
    Type: Application
    Filed: January 7, 2016
    Publication date: July 7, 2016
    Applicant: Nutrition Science Partners Limited
    Inventors: Jifeng DUAN, Zhiming MA, Xiaoqiang YAN, Weihan ZHANG, Tao WANG, Yu CAI
  • Publication number: 20140315846
    Abstract: An extract of Andrographis paniculata extract containing androgapholide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysaccharides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.
    Type: Application
    Filed: July 1, 2014
    Publication date: October 23, 2014
    Inventors: Jifeng DUAN, Zhiming MA, Xiaoqiang YAN, Weihan ZHANG, Tao WANG, Yu CAI
  • Publication number: 20140004212
    Abstract: An extract of Andrographis paniculata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographotide, neoandrographolide, polysacchorides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.
    Type: Application
    Filed: September 6, 2013
    Publication date: January 2, 2014
    Applicant: Nutrition Science Partners Limited
    Inventors: Jifeng DUAN, Zhiming MA, Xiaoqiang YAN, Weihan ZHANG, Tao WANG, Yu CAI
  • Patent number: 8557302
    Abstract: An extract of Andrographis paniculata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysacchorides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.
    Type: Grant
    Filed: November 4, 2008
    Date of Patent: October 15, 2013
    Assignee: Nutrition Science Partners Limited
    Inventors: Jifeng Duan, Zhiming Ma, Xiaoqiang Yan, Weihan Zhang, Tao Wang, Yu Cai
  • Patent number: 8557308
    Abstract: An extract of Andrographis paniculata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysacchorides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: October 15, 2013
    Assignee: Nutrition Science Partners Limited
    Inventors: Jifeng Duan, Zhiming Ma, Xiaoqiang Yan, Weihan Zhang, Tao Wang, Yu Cai
  • Publication number: 20130023493
    Abstract: An extract of Andrographis paniculata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysacchorides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.
    Type: Application
    Filed: September 11, 2012
    Publication date: January 24, 2013
    Applicant: HUTCHISON MEDIPHARMA ENTERPRISES LIMITED
    Inventors: Jifeng Duan, Zhiming Ma, Xiaoqiang Yan, Weihan Zhang, Tao Wang, Yu Cai
  • Patent number: 7625945
    Abstract: This invention relates to a method of inhibiting the expression of TNF? or IL-1? with a compound of the following formula: wherein R1 and R2 are defined herein. It also relates to is a method of treating inflammatory bowel disease with such a compound.
    Type: Grant
    Filed: March 11, 2005
    Date of Patent: December 1, 2009
    Assignee: Hutchison MediPharma Enterprises Ltd.
    Inventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Ke Pan, Weihan Zhang, Jianrong Hong, Jeff Duan, Yu Cai
  • Publication number: 20090117210
    Abstract: An extract of Andrographis paniculata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysacchorides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.
    Type: Application
    Filed: November 4, 2008
    Publication date: May 7, 2009
    Applicant: Hutchison MediPharma Enterprises Limited
    Inventors: Jifeng Duan, Zhiming Ma, Xiaoqiang Yan, Weihan Zhang, Tao Wang, Yu Cai
  • Publication number: 20090117209
    Abstract: An extract of Andrographis paniculata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysacchlorides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.
    Type: Application
    Filed: November 2, 2007
    Publication date: May 7, 2009
    Applicant: Hutchison Medipharma Enterprises Limited
    Inventors: Jifeng Duan, Zhiming Ma, Xiaoqiang Yan, Weihan Zhang, Tao Wang, Yu Cai
  • Patent number: 7341748
    Abstract: This invention relates to a method of inhibiting TNF? or IL-1? expression with an extract of Andrographis paniculata. The extract contains andrographolide, 14-deoxy-andrographolide, 14-deoxy-11,12-dehydrogen-andrographolide, and neoandrographolide.
    Type: Grant
    Filed: April 27, 2005
    Date of Patent: March 11, 2008
    Assignee: Hutchison MediPharma Enterprises Limited
    Inventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Weihan Zhang, Jifeng Duan, Yu Cai
  • Publication number: 20060246156
    Abstract: This invention relates to a method of inhibiting TNF? or IL-1? expression with an extract of Andrographis paniculata. The extract contains andrographolide, 14-deoxy-andrographolide, 14-deoxy-11,12-dehydrogen-andrographolide, and neoandrographolide.
    Type: Application
    Filed: April 27, 2005
    Publication date: November 2, 2006
    Inventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Weihan Zhang, Jifeng Duan, Yu Cai
  • Publication number: 20050226943
    Abstract: Compositions containing a Sophora flavescens flavonoids extract or its active ingredients, Kurarinone, 2?-methoxy-Kurarinone, and Sophoraflavanone G are described. Also disclosed is a method of treating TNF? and IL-1? related diseases using such compositions.
    Type: Application
    Filed: March 30, 2005
    Publication date: October 13, 2005
    Inventors: Xiaoqiang Yan, Yumin Cui, Tao Wang, Zhiming Ma, Ke Pan, Weihan Zhang, Weihui Huang, Jianrong Hong, Jeff Duan, Yu Cai
  • Publication number: 20050215628
    Abstract: This invention relates to a method of inhibiting the expression of TNF? or IL-1? with a compound of the following formula: wherein R1 and R2 are defined herein. It also relates to is a method of treating inflammatory bowel disease with such a compound.
    Type: Application
    Filed: March 11, 2005
    Publication date: September 29, 2005
    Inventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Ke Pan, Weihan Zhang, Jianrong Hong, Jeff Duan, Yu Cai
  • Patent number: RE42718
    Abstract: This invention relates to a method of inhibiting TNF? or IL-1? expression with an extract of Andrographis paniculata. The extract contains andrographolide, 14-deoxy-andrographolide, 14-deoxy-11,12-dehydrogen-andrographolide, and neoandrographolide.
    Type: Grant
    Filed: March 4, 2010
    Date of Patent: September 20, 2011
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Weihan Zhang, Jifeng Duan, Yu Cai
  • Patent number: RE43423
    Abstract: This invention relates to a method of inhibiting TNF? or IL-1? expression with an extract of Andrographis paniculata. The extract contains andrographolide, 14-deoxy-andrographolide, 14-deoxy-11,12-dehydrogen-andrographolide, and neoandrographolide.
    Type: Grant
    Filed: July 22, 2011
    Date of Patent: May 29, 2012
    Assignee: Hutchison MediPharma Enterprises Limited
    Inventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Weihan Zhang, Jifeng Duan, Yu Cai